MktsMarkets

Charles River Laboratories International, Inc.
NYSE: CRLKey statistics
CRL News
Stories mentioning CRL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 28 | Q4 '25Dec 27 | Q3 '25Sep 27 | Q2 '25Jun 28 | Q1 '25Mar 29 | Q4 '24Dec 28 | Q3 '24Sep 28 | Q2 '24Jun 29 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 995,830 | 994,227 | 1,004,852 | 1,032,135 | 984,168 | 1,002,549 | 1,009,763 | 1,026,117 |
| Cost of Goods Sold | 660,742 | 672,404 | ||||||
| Gross Profit | 349,021 | 353,713 | ||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 159,422 | 196,136 | 177,589 | 191,549 | 177,799 | 195,708 | 199,213 | 169,791 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 119,897 | (283,440) | 133,799 | 100,134 | 74,669 | (167,687) | 117,405 | 151,652 |
| Interest Income | 1,033 | 1,017 | 1,422 | 1,097 | 1,404 | 1,835 | 1,528 | 3,010 |
| Interest Expense | ||||||||
| Other Expense | (124,130) | 12,099 | (22,618) | 154.00 | (12,211) | (22,705) | 2,592 | (2,240) |
| Pretax Income | ||||||||
| Tax Provision | (15,140) | (17,809) | 31,644 | 18,725 | 10,100 | (3,044) | 20,946 | 25,392 |
| Net Income (Loss) | (14,843) | (276,555) | 54,422 | 52,326 | 25,469 | (214,495) | 69,657 | 94,081 |
| Earnings Per Share (Basic) | (0.30) | (5.58) | 1.11 | 1.06 | 0.50 | (4.17) | 1.34 | 1.75 |
| Earnings Per Share (Diluted) | (0.30) | (5.58) | 1.10 | 1.06 | 0.50 | (4.15) | 1.33 | 1.74 |
| Weighted Average Shares Outstanding (Basic) | 48,951 | 49,564 | 49,213 | 49,149 | 50,677 | 51,380 | 51,394 | 51,551 |
| Weighted Average Shares Outstanding (Diluted) | 48,951 | 49,564 | 49,426 | 49,316 | 50,853 | 51,628 | 51,583 | 51,846 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CRL
Charles River Laboratories International, Inc. (NYSE: CRL) is a stock listed on the New York Stock Exchange under the ticker symbol CRL. It last traded at $357.37 (Nov 9, 2026, 3:30 PM ET), up 5.9% on the day. That gives Charles River Laboratories International a market capitalisation of $16.2B and a price-to-earnings ratio of 402.4.
Over the past 52 weeks CRL has traded between $146.20 and $379.63.
Revenue for the quarter ended Mar 28, 2026 was $995.8M; a net loss of $14.8M. Revenue was up 1.2% from $984.2M in the quarter ended Mar 29, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 28, 2026 | $995.8M | -$14.8M | -1.5% |
| Dec 27, 2025 | $994.2M | -$276.6M | -27.8% |
| Sep 27, 2025 | $1.0B | $54.4M | 5.4% |
| Jun 28, 2025 | $1.0B | $52.3M | 5.1% |
From Charles River Laboratories International’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…